Lilly's Mounjaro and Zepbound contribute to big revenue boost, drugmaker says
Eli Lilly & Co. said Thursday that its Type 2 diabetes drug Mounjaro and its weight-loss and diabetes drug Zepbound drove a 45% increase in fourth-quarter revenue to $13.53 billion.
TMDX ALERT: BFA Law Notifies Transmedics Group Investors To Contact The Firm About Ongoing Securities Fraud Investigation (NASDAQ:TMDX)
In truth, it appears that TransMedics fueled its growth by engaging in an anti-competitive scheme, including providing kickbacks to medical providers. The company further boosted growth by engaging in ...
MiningNews.net17h
QMines spears thick copper at Scorpion
Queensland explorer QMines has speared an impressively thick, high-grade zone of mineralisation in one of the final holes ...
Stockhead on MSN21h
Thick high grade copper: Scorpion packs a major sting at QMines’ Develin Creek
QMines (ASX:QML) has reported a string of stunning high grade copper intercepts at its Develin Creek project near Rockhampton ...